Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study analyzed social media posts to assess pet toxicosis from topical minoxidil exposure, finding that many pet owners were unaware of its toxicity risks, particularly for cats, and highlighted a significant need for increased educational efforts to prevent such incidents.

This study introduces a new multiaxial bioreactor system that uniformly stretches tissue-engineered skin grafts and improves skin tissue maturation through enhanced cellular distribution and environmental monitoring.

This systematic review reported that while combining low-dose oral minoxidil with Janus kinase inhibitors may enhance treatment outcomes in alopecia areata, the evidence remains weak due to limited sample sizes and potential publication bias, and more rigorous trials are necessary to assess efficacy and safety.

This study examined 16 sporadic trichoblastic tumors and found that although one showed malignant transformation, clinical follow-up revealed no residual or metastatic disease. RNA sequencing indicated a high tumor mutational burden and absence of a UV-related signature, helping to distinguish these tumors from similar growths.

This review suggests weak associations between GLP-1 receptor agonists and increased reports of hair loss, particularly with semaglutide and tirzepatide, while cases of hair regrowth were also occasionally documented.

This study reports that prenatal and prepubertal exposure to organochlorine compounds and perfluoroalkyl substances may affect pubertal development at age 12, with observed changes in development patterns in both girls and boys, highlighting the need for further research.

In this case report, the researchers diagnosed a large trichobezoar in a 7-year-old girl with gastrointestinal symptoms and weight loss through endoscopy after inconclusive imaging, highlighting endoscopy's importance for accurate diagnosis and the need for surgical and behavioral intervention to prevent recurrence.

In this systematic review and meta-analysis, researchers evaluated the link between alopecia areata and adverse pregnancy outcomes, motivated by the condition's association with other autoimmune diseases that increase pregnancy risks. Results are not provided in the abstract.

Some JAK inhibitors are effective for significant hair regrowth in alopecia areata.

This study found that fibroblasts from Emery-Dreifuss muscular dystrophy patients with certain genetic mutations overexpress markers of fibrosis, and gene correction techniques reduced fibrogenic molecule expression in cell models, suggesting potential therapeutic applications.

Online resources for hair loss need better quality and readability.

This review on Graves' disease explains its major role in causing hyperthyroidism, details genetic, environmental, and immunological risk factors, diagnoses, treatment options like anti-thyroid medications, and highlights potential complications such as ophthalmopathy and cardiovascular issues, noting prognosis varies by age.

This study found that RNase L acts as a regeneration repressor gene in mammals, as seen in Rnasel-/- mice which showed increased regenerative capacity and elevated Wound Induced Hair Neogenesis through enhanced IL-36α signaling, suggesting a tradeoff between regeneration and immune regulation.

In this review, researchers investigated 14 articles on how various dietary measures may influence hair regrowth by possibly reducing intestinal and skin inflammation in patients with alopecia areata.

In this narrative review, researchers examined common misconceptions and questions about creatine monohydrate, addressing issues such as its potential effects on muscle benefits without exercise, interactions with caffeine, inflammatory properties, safety during pregnancy, and effects on adolescents, among others.

JAK inhibitors may help treat both alopecia areata and vitiligo, but more research is needed.

This correspondence explores the potential relationship between lichen planopilaris and skin cancer but reports no new research findings.

This study assessed the impact of a New York Times article on consumer interest in androgenetic alopecia treatments by surveying dermatologists about practice trends and analyzing online search data related to low dose oral minoxidil and hair loss from February 2022 to February 2023.

This study observed that many individuals with alopecia areata seek or receive dietary and nutritional advice to manage their condition, often making changes such as taking supplements or adding specific foods, yet most reported no change in their disease status.

No specific results were reported in this abstract; it aims to explore the psychological effects of hair loss conditions like Chronic Telogen Effluvium and Androgenetic Alopecia, emphasizing the potential link between micronutrient deficiency and hair health.

In this case study, an 11-month-old cat developed non-pruritic hair loss in the dorso-lumbar area after a road accident, with histopathological examination revealing post-traumatic changes such as absence of hair follicles and pyogranulomas.

This study found that after 6 months of taking an oral supplement, patients with chronic telogen effluvium or androgenetic alopecia experienced a statistically significant increase in hair density and overall improved hair appearance compared to those taking a placebo, with the supplement being well tolerated.

This study identified three new genetic loci linked to sweat gland density in a GWAS involving 6,210 Han Chinese individuals, highlighting potential targets for understanding conditions like anhidrosis and hyperhidrosis and emphasizing the use of quantitative traits in genetic dermatology research.

This study observed that exposure to different wavelengths of light affects opsin and clock gene responses in skin cells, suggesting potential therapeutic approaches using photobiomodulation for dermatological conditions like psoriasis and wound healing.

In this integrative review, researchers assessed the efficacy of oral minoxidil for treating alopecia, finding that it appears effective, especially for female androgenetic alopecia, though evidence quality is very low and side effects limit its use compared to topical forms.

In this study conducted at the University of Michigan Alopecia Clinic, survey respondents demonstrated high awareness (97.9%) of topical minoxidil for hair loss, with medical professionals being the most influential information source (34%). Concerns about usage included continuous application (46.8%) and skepticism about regrowth (29.8%).

This study proposes that combining trazodone and clomiphene citrate could potentially restore libido synaptic circuits and treat post-finasteride syndrome, which involves persistent sexual dysfunction after discontinuing finasteride treatment.

Media coverage increased public interest in oral minoxidil for hair loss but may also spread misinformation.

The researchers proposed that an epigenetic change in brain androgen receptors caused by finasteride could lead to post finasteride syndrome, while trazodone might reverse this effect by altering the epigenetic expression related to erection and libido.

In this study, researchers observed that twins with a novel de novo nonsense variant in HRAS exhibited distinctive features, including neuropsychiatric symptoms, potentially indicating a wider clinical spectrum for conditions known as RASopathies.